Information Library

Results for: Partnership Structures

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Partnering to Maximize Rewards in Pharmerging Markets

    White Paper — September 15, 2011
    In the past few years so-called “pharmerging” markets have been heralded as the hottest growth area for biopharmaceutical drugs. With large populations, growing disposable income and unmet medical needs, these markets have seen doubledigit growth rates in pharmaceutical spending.

  • Podcast: Key FSP stakeholders - roles, relationships and impacts

    Hear from the Experts — May 16, 2011
    Fred Cooley, Senior Director, Clinical Operations, North America Field Monitoring Group, describes key stakeholders in Functional Service Provider Relationships.

  • Podcast: The Benefits and Drawbacks of Functional Service Provider Arrangements (FSPs)

    Hear from the Experts — May 16, 2011
    Ian Birks, Vice President, Integration, Resourcing, Metrics & Reporting, discusses the benefits and drawbacks of Functional Service Provider Arrangements (FSPs)

  • The New Health Alliance

    White Paper — January 10, 2011
    Biopharmaceutical companies must explore alternative strategic alliances that meet the needs of the New Health and produce medicines that demonstrate value to the entire constellation of stakeholders.

  • PHARMAXIS SELECTS QUINTILES TO COMMERCIALIZE BRONCHITOL

    Press Release — August 31, 2010 – Quintiles announced a strategic agreement with Pharmaxis to provide a broad range of commercial solutions to support the European launch of Bronchitol®, an innovative treatment for cystic fibrosis.

  • Capital - sharing risks, expanding opportunities

    Brochure — July 14, 2010
    This Capital brochure reviews how Quintiles helps biopharma allies maximize the value of assets, reduce risk, accelerate outcomes and increase rewards.

  • Targeting Oncology

    Brochure — June 2, 2010
    Learn more about Quintiles leadership in oncology product development and commercialization.

  • Eric Siemers, MD

    Hear from the Experts — May 20, 2010
    Eric Siemers, MD Medical Director, Alzheimer’s Disease Eli Lilly Eric Siemers, M.D. is Medical Director of the Alzheimer’s Disease Team at Eli Lilly

  • Focused Co-Promotion

    Case Study — May 9, 2010
    Roche Italy needed to find new, cost-effective ways to underpin sales of mature products. Uncover what happened when a unique partnership with Quintiles reinforced sales growth.

  • PharmAsia News Article Reprint

    Media Coverage — March 1, 2010
    Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News.

Page 1 of 3 (25 results)

Subscribe to Email Based on Your Interests

Set preferences